[1] |
Dastranj M, Farahani A, Hashemi Shahraki A, et al. Molecular identification and distribution of non-tuberculous mycobacteria isolated from clinical specimens by PCR-sequencing method in West of Iran. Clin Respir J, 2018,12(3):996-1002. doi: 10.1111/crj.12617.
doi: 10.1111/crj.12617
pmid: 28224727
|
[2] |
Kim SH, Shin JH. Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal, 2018,32(1):e22184. doi: 10.1002/jcla.22184.
doi: 10.1002/jcla.22184
URL
|
[3] |
中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020,43(11):918-946. doi: 10.3760/cma.j.cn112147-20200508-00570.
doi: 10.3760/cma.j.cn112147-20200508-00570
|
[4] |
赵雁林, 逄宇. 结核病实验室检验规程. 北京: 人民卫生出版社, 2015: 45-51.
|
[5] |
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis, 2020,71(4):e1-e36. doi: 10.1093/cid/ciaa241.
doi: 10.1093/cid/ciaa241
URL
|
[6] |
沙巍, 肖和平. 再议非结核分枝杆菌的危害性. 中华结核和呼吸杂志, 2018,41(2):83-85. doi: 10.3760/cma.j.issn.1001-0939.2018.02.002.
doi: 10.3760/cma.j.issn.1001-0939.2018.02.002
|
[7] |
Marras TK, Mehta M, Chedore P, et al. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung, 2010,188(4):289-299. doi: 10.1007/s00408-010-9241-8.
doi: 10.1007/s00408-010-9241-8
URL
|
[8] |
李燕明, 佟训靓, 逄宇, 等. 鸟分枝杆菌复合群药物敏感性试验结果及临床特征分析. 中国防痨杂志, 2015,37(6):622-627. doi: 10.3969/j.issn.1000-6621.2015.06.010.
doi: 10.3969/j.issn.1000-6621.2015.06.010
|
[9] |
张洁, 苏建荣, 丁北川, 等. 北京地区非结核分枝杆菌菌种分布及耐药性研究. 中华结核和呼吸杂志, 2017,40(3):210-214. doi: 10.3760/cma.j.issn.1001-0939.2017.03.013.
doi: 10.3760/cma.j.issn.1001-0939.2017.03.013
|
[10] |
张亚楠, 段鸿飞. 鸟-胞内分枝杆菌复合群肺病的诊断和治疗进展. 中国防痨杂志, 2017,39(10):1126-1129. doi: 10.3969/j.issn.1000-6621.2017.10.018.
doi: 10.3969/j.issn.1000-6621.2017.10.018
|
[11] |
周荣真, 吴秀丽, 王健, 等. 鸟-胞内分枝杆菌肺病伴空洞的CT特征分析. 中国防痨杂志, 2019,41(9):1009-1014. doi: 10.3969/j.issn.1000-6621.2019.09.018.
doi: 10.3969/j.issn.1000-6621.2019.09.018
|
[12] |
李芳, 贺伟, 周新华, 等. 非结核分枝杆菌肺病和活动性肺结核的高分辨率CT表现异同性分析. 中国防痨杂志, 2018,40(5):499-505. doi: 10.3969/j.issn.1000-6621.2018.05.012.
doi: 10.3969/j.issn.1000-6621.2018.05.012
|
[13] |
陆伟, 傅衍勇. 我国耐药结核病控制的现状及展望. 结核病与肺部健康杂志, 2016,5(4):259-261. doi: 10.3969/j.issn.2095-3755.2016.04.002.
doi: 10.3969/j.issn.2095-3755.2016.04.002
|
[14] |
唐神结, 朱友生, 张青. 非结核分枝杆菌肺病治疗面临的难点与困惑. 中华结核和呼吸杂志, 2012,35(8):566-568. doi: 10.3760/cma.j.issn.1001-0939.2012.08.004.
doi: 10.3760/cma.j.issn.1001-0939.2012.08.004
|
[15] |
唐惠红, 何志青, 罗春明, 等. 广州市越秀区2008—2011年非结核分枝杆菌肺病临床特征及影响治愈因素分析. 实用预防医学, 2015,22(11):1316-1322. doi: 10.3969/j.issn.1006-3110.2015.011.011.
doi: 10.3969/j.issn.1006-3110.2015.011.011
|
[16] |
Kadota T, Matsui H, Hirose T, et al. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. BMC Infect Dis, 2016,16:31. doi: 10.1186/s12879-016-1384-7.
doi: 10.1186/s12879-016-1384-7
|